Skip Navigation



Human Reproduction Update Advance Access published online on August 5, 2004

Human Reproduction Update, doi:10.1093/humupd/dmh037
Copyright © 2004 by the European Society of Human Reproduction and Embryology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
10/5/421    most recent
dmh037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rivera-Woll, L.M.
Right arrow Articles by Burger, H.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivera-Woll, L.M.
Right arrow Articles by Burger, H.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received February 9, 2004
Accepted July 2, 2004

Review

Androgen insufficiency in women: diagnostic and therapeutic implications

L.M. Rivera-Woll 1*, M. Papalia 1, S.R. Davis 2, H.G. Burger 3

1 The Jean Hailes Foundation Research Unit, 173 Carinish Road, Clayton, Victoria, Australia, 3168
2 The Jean Hailes Foundation NHMRC Centre of Clinical Research Excellence, Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia, 3168
3 Prince Henry's Institute of Medical Research, 246 Clayton Road, Clayton, Victoria, Australia, 3168

* To whom correspondence should be addressed. E-mail: research{at}jeanhailes.org.au.


   Abstract

The proposed key symptoms of the female androgen insufficiency syndrome (FAIS) include reduced libido, diminished well being and lowered mood. The diagnosis of FAIS is made on the basis of these symptoms in the setting of a low serum free testosterone level. However, there is currently no readily available inexpensive assay which reliably measures free testosterone levels in the female range. The diagnosis of FAIS is further complicated by the lack of data demonstrating a minimum serum free testosterone level which, if below this, correlates with the symptoms of FAIS. Despite the complexities involved with defining FAIS, the symptoms have been reported to respond well to testosterone replacement. There is a need for formulations of testosterone therapy specifically designed for use in women, along with clear guidelines regarding optimal therapeutic doses and long-term safety data.

Keywords: androgens; female androgen insufficiency syndrome; testosterone.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
M. Yoshioka, A. Boivin, C. Bolduc, and J. St-Amand
Gender difference of androgen actions on skeletal muscle transcriptome
J. Mol. Endocrinol., August 1, 2007; 39(2): 119 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. H. Slagter, L. J.G. Gooren, A. Scorilas, C. D. Petraki, and E. P. Diamandis
Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals
J. Histochem. Cytochem., August 1, 2006; 54(8): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.-N. Hugues
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study
Hum. Reprod., May 1, 2006; 21(5): 1204 - 1211.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.